Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin LeWinter

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Cardiovascular Medicine|November 7, 2001
Diabetic CardiomyopathySusanne Trost, Martin LeWinter
JAMA|October 14, 2015
Evaluation and Treatment of Pericarditis: A Systematic ReviewMassimo Imazio, Fiorenzo Gaita, Martin LeWinter
Heart Failure Reviews|November 4, 2017
Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing conceptMarkus Meyer, Mehdi Rambod, Martin LeWinter
Heart Failure Reviews|January 18, 2006
Titin: physiological function and role in cardiomyopathy and failureHenk Granzier, Yiming Wu, Labeit Siegfried, et al.
Clinical Cardiology|April 26, 2018
Left ventricular end-diastolic volume predicts exercise capacity in patients with a normal ejection fractionLakshmi Nambiar, Anita Li, Alan Howard, et al.
Journal of Cardiac Failure|July 21, 2018
Safety and Feasibility of a Nocturnal Heart Rate Elevation-Exploration of a Novel Treatment ConceptSrinath C Yeshwant, Michael R Zile, Michael R Lewis, et al.
European Heart Journal|September 16, 2021
Anti-interleukin-1 agents for pericarditis: a primer for cardiologistsMassimo Imazio, George Lazaros, Marco Gattorno, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 16, 2021
SERCA2a-phospholamban interaction monitored by an interposed circularly permutated green fluorescent proteinMaren E Arnold, Wolfgang R Dostmann, Jody Martin, et al.
Heart (British Cardiac Society)|March 19, 2021
Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic review and meta-analysisMassimo Imazio, Alessandro Andreis, Francesco Piroli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 23, 2013
DRainage Or Pericardiocentesis alone for recurrent nonmalignant, nonbacterial pericardial effusions requiring intervention: rationale and design of the DROP trial, a randomized, open-label, multicenter studyMassimo Imazio, Riccardo Belli, Federico Beqaraj, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Cardiovascular Medicine|November 7, 2001
Diabetic CardiomyopathySusanne Trost, Martin LeWinter
JAMA|October 14, 2015
Evaluation and Treatment of Pericarditis: A Systematic ReviewMassimo Imazio, Fiorenzo Gaita, Martin LeWinter
Heart Failure Reviews|November 4, 2017
Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing conceptMarkus Meyer, Mehdi Rambod, Martin LeWinter
Heart Failure Reviews|January 18, 2006
Titin: physiological function and role in cardiomyopathy and failureHenk Granzier, Yiming Wu, Labeit Siegfried, et al.
Clinical Cardiology|April 26, 2018
Left ventricular end-diastolic volume predicts exercise capacity in patients with a normal ejection fractionLakshmi Nambiar, Anita Li, Alan Howard, et al.
Journal of Cardiac Failure|July 21, 2018
Safety and Feasibility of a Nocturnal Heart Rate Elevation-Exploration of a Novel Treatment ConceptSrinath C Yeshwant, Michael R Zile, Michael R Lewis, et al.
European Heart Journal|September 16, 2021
Anti-interleukin-1 agents for pericarditis: a primer for cardiologistsMassimo Imazio, George Lazaros, Marco Gattorno, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 16, 2021
SERCA2a-phospholamban interaction monitored by an interposed circularly permutated green fluorescent proteinMaren E Arnold, Wolfgang R Dostmann, Jody Martin, et al.
Heart (British Cardiac Society)|March 19, 2021
Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic review and meta-analysisMassimo Imazio, Alessandro Andreis, Francesco Piroli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 23, 2013
DRainage Or Pericardiocentesis alone for recurrent nonmalignant, nonbacterial pericardial effusions requiring intervention: rationale and design of the DROP trial, a randomized, open-label, multicenter studyMassimo Imazio, Riccardo Belli, Federico Beqaraj, et al.
Pageof 3